← Back to Search

Culturally Adapted Treatment for Substance Abuse

N/A

Recruiting

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, after study completion, and up to 3 months post-intervention, an average of 6 months.

Awards & highlights

Study Summary

This trial aims to study how ethnic and racial discrimination affects alcohol and drug use in Black justice-involved youth. Interviews and focus groups will be conducted.

Who is the study for?

This trial is for Black or African American youth aged 12-17 who are currently on community probation. It aims to address substance use disorders by considering the impact of racial discrimination in treatment.Check my eligibility

What is being tested?

The study is testing a culturally adapted treatment program for adolescent substance abuse, focusing on the unique experiences of Black Justice-Involved Youth and how ethnic and racial discrimination affects recovery.See study design

What are the potential side effects?

Since this trial involves interviews and focus groups rather than medical interventions, there are no direct physical side effects. However, discussing sensitive topics may cause emotional discomfort.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, after study completion, and up to 3 months post-intervention, an average of 6 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, after study completion, and up to 3 months post-intervention, an average of 6 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, after study completion, and up to 3 months post-intervention, an average of 6 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility and Acceptability

Secondary outcome measures

Change in discrimination distress

Change in substance use

Trial Design

1Treatment groups

Experimental Treatment

Group I: ADAP-ITT Phase 8Experimental Treatment1 Intervention

Phase 8 consists of piloting the culturally adapted CYT intervention with 30 Black JIY to examine feasibility and acceptability.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor

933 Previous Clinical Trials

7,394,581 Total Patients Enrolled

5 Trials studying Substance Abuse

1,174 Patients Enrolled for Substance Abuse

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age of qualification for this trial below 30 years old?

"This trial is seeking adolescents aged between 12 and 17 years old."

Answered by AI

Are there still opportunities for participants in this clinical experiment?

"Based on the clinicaltrials.gov listing, this study is still pursuing qualified patients. It was opened for recruitment on September 30th 2022 and its information were updated as recently as August 17th 2023."

Answered by AI

Who is qualified to participate in this experiment?

"This research trial is searching for 55 minors aged 12 to 17 who suffer from a substance abuse problem. Successful applicants will be invited to join the study."

Answered by AI

What is the uppermost participant capacity of this medical experiment?

"Correct. Per the information hosted on clinicaltrials.gov, this research study is still actively seeking out participants and was initially posted on September 30th 2022. Up to 55 patients are being recruited from a single medical centre for enrollment in the trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cultural Adaptation of Drug Treatment for DJJ Youth

Brittany Bryant 2022. "Cultural Adaptation of Drug Treatment for DJJ Youth". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06003725.